In contrast, AGR integrates inflammatory status (via globulin) and nutritional status (via albumin), providing a dual mechanism for assessing depression risk and potentially making it more suitable for predicting depression in specific populations such as cancer patients. This evidence concerns the gene ALB and major depressive disorder.